Status:
COMPLETED
Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Systemic Scleroderma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Systemic sclerosis (SSc) is a connective-tissue disease characterized by excessive collagen deposition, vascular hyper-reactivity and obliterative microvascular phenomena leading to disability, handic...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Men or women aged from 18 years or more, with diagnostic of SSc considering the ACR and/or Leroy and Medsger's criteria.
- HAQ greater than or equal to 0.5
- A perception of limitation of mouth opening and/or at least one limitation in range of motion due to illness
- Good understanding of the French language
- Exclusion Criteria :
- Associated chronic handicap diseases (stroke, multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease, amputated ....)
- Any underlying disease that may be incompatible with the management, discovery at the inclusion visit
- Cognitive problems making it impossible to assess the primary outcome measure
- Patients with a standardized rehabilitation program within 6 months prior to inclusion
- Impairment of comprehension or expression of the French language
- Patients participating in another clinical trial or participated in another clinical trial in the previous 3 months.
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT00318188
Start Date
September 1 2005
End Date
January 1 2014
Last Update
April 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reeducation and readaptation Department
Paris, France, 75679